Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × AEG 35156 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2 Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1

Interventions

pembrolizumab 159 Gemcitabine 141 Paclitaxel 134 Carboplatin 120 Bevacizumab 114 Surveys and Questionnaires 101 Cyclophosphamide 99 Cisplatin 99 Docetaxel 96 Blood Specimen Collection 95 Exercise 91 Nivolumab 85 Fluorouracil 78 Capecitabine 78 Dexamethasone 73 Radiotherapy 71 Irinotecan 66 Pemetrexed 61 Standard of Care 60 Oxaliplatin 60 Leucovorin 56 Drug Therapy 56 Cetuximab 50 Erlotinib Hydrochloride 46 atezolizumab 45 Sorafenib 45 Doxorubicin 44 Interviews as Topic 43 Ipilimumab 38 130-nm albumin-bound paclitaxel 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00385775 2008-08-21

Study of XIAP Antisense for Advanced Cancers

Aegera Therapeutics

Phase 1 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡